Enveda secures $311M to bring more nature-derived AI drugs into clinical trials
The round valued the AI biotech at $2 billion. It is currently testing drugs that treat skin conditions and preserve weight loss after stopping GLP-1s.
OpenAI and Perplexity are launching AI shopping assistants, but competing startups aren’t sweating it
Startup founders building AI shopping tools think general-purpose models are too broad to deliver truly personalized shopping experiences.
Comments
Post a Comment